David Benito Laorga’s Haemophilia Team Hosts Hemosfera
David Benito Laorga, Business Unit Director and Management Team Member Novo Nordisk Spanish Affiliate, shared on LinkedIn:
”This weekend, our haemophilia team hosted Hemosfera, a truly innovative meeting centered on a new treatment with the potential to reduce treatment burden, improve quality of life, and open new possibilities for patients and families.
I’m especially proud of the team behind the scenes.
From concept to execution, this event was powered by strong ownership, deep commitment, and a shared conviction that meaningful innovation requires doing things differently—and doing them well.
This is what high-performing teams look like.
My sincere thanks as well to all the speakers for the depth and quality of the discussions.
Your insights and engagement were critical to making this a truly valuable and impactful event.
Proud of the team. Motivated by the impact we can create for patients.”
Stay updated with Hemostasis Today.
-
Mar 19, 2026, 17:14Akinchan Bhardwaj: Differences in Bleeding Outcomes Among DOACs
-
Mar 19, 2026, 17:03How Personal Experiences Can Support Self‑Advocacy and Help Improve Healthcare Outcomes – Hemophilia Alliance
-
Mar 19, 2026, 16:54X. Long Zheng: Unpacking the Real-World Challenges of ADAMTS13 on ISTH Pulse Podcast
-
Mar 19, 2026, 16:50Zain Khalpey: Predictive Imaging and AI in Aortic Dissection Risk Assessment
-
Mar 19, 2026, 16:49Marilena Vrana: Access, Resilience, and Policy Priorities Ahead of IPPC2026
-
Mar 19, 2026, 16:46Connie Montgomery: Celebrating Heroes of the Bleeding Disorders Community
-
Mar 19, 2026, 16:44Anita Brikman: Advancing Plasma Availability and Access to Plasma-Derived Therapies in India
-
Mar 19, 2026, 16:41Sinju Thomas: Early Initiation and Collaboration are Critical in Stem Cell Collection for Haemoglobinopathies
-
Mar 19, 2026, 16:34Aloke Finn: The Role of Silent Plaque Rupture in Atherosclerotic Disease Evolution